19 Jul 2013 09:51
Annual Information Update 2013
BTG plc (LSE:BTG) ("the Company") is pleased to provide its annual information update, in accordance with the requirements of the Prospectus Rule 5.2. This update refers to information that has been published or made available by the Company to the public over the twelve months ending today. To avoid an unnecessarily lengthy document, information is referred to in this update rather than included in full.
The information referred to in this update was up to date at the time the information was published but some information may now be out-of-date.
(1) Announcements made via RNS, a Regulatory Information Service
All of the documents listed below were published via RNS, a Regulatory Information Service on or around the dates indicated.
Date of publication | Brief Description of announcement |
17 July 2013 | Directors' Interests in shares of BTG plc |
16 July 2013 | Results of AGM |
16 July 2013 | Interim Management Statement |
15 July 2013 | Completion of Acquisition of TheraSphere |
11 July 2013 | Result of EGM |
8 July 2013 | Completion of EKOS Acquisition |
28 June 2013 | Total voting rights and share capital |
28 June 2013 27 June 2013 | Positive CHMP Opinion for LEMTRADA Notification of major interest in BTG plc shares |
21 June 2013 | Notice of EGM |
18 June 2013 | Additional Listing of shares |
17 June 2013 | Annual Financial report |
31 May 2013 | Notification of major interest in BTG plc shares |
31 May 2013 | Total voting rights and share capital |
30 May 2013 | Notification of major interest in BTG plc shares |
29 May 2013 | Total voting rights and share capital |
24 May 2013 | Directors' Interests in shares of BTG plc |
24 May 2013 | Notification of major interest in BTG plc shares |
23 May 2013 | Notification of major interest in BTG plc shares |
23 May 2013 | Results of Placing |
23 May 2013 | Acquisition of EKOS |
23 May 2013 | Proposed Acquisition of TheraSphere |
23 May 2013 | Additional Listing of shares |
20 May 2013 | Final Results announcement |
30 April 2013 | Total voting rights and share capital |
15 April 2013 | Notification of major interest in BTG plc shares |
15 April 2013 | Notification of major interest in BTG plc shares |
12 April 2013 | Varisolve® NDA accepted for full review by FDA |
4 April 2013 | Close Period Update |
2 April 2013 | Block listing Return |
28 March 2013 | Total voting rights and share capital |
21 March 2013 | Directors' Interests in shares of BTG plc |
28 February 2013 | Total voting rights and share capital |
4 February 2013 | Varisolve® NDA submitted to the FDA |
31 January 2013 | Total voting rights and share capital |
31 January 2013 | Interim Management Statement |
2 January 2013 | Total voting rights and share capital |
20 December 2012 | Total voting rights and share capital |
17 December 2012 | Total voting rights and share capital |
14 December 2012 | Notification of major interest in BTG plc shares |
11 December 2012 | Directorate change |
11 December 2012 | US FDA approves expanded ZYTIGA indication |
10 December 2012 | Total voting rights and share capital |
30 November 2012 | Total voting rights and share capital |
26 November 2012 | Total voting rights and share capital |
20 November 2012 | Total voting rights and share capital |
20 November 2012 | ZYTIGA receives positive opinion in EU |
19 November 2012 | Phase III trials of Varisolve® PEM presented at ACP |
15 November 2012 | Total voting rights and share capital |
12 November 2012 | Directors' Interests in shares of BTG plc |
8 November 2012 | Half Yearly Report |
31 October 2012 | Total voting rights and share capital |
25 October 2012 | Total voting rights and share capita |
19 October 2012 | Notice of Results |
18 October 2012 | Total voting rights and share capital |
17 October 2012 | Block listing Return |
11 October 2012 | Total voting rights and share capital |
3 October 2012 | Total voting rights and share capital |
3 October 2012 | Trading Statement |
28 September 2012 | Total voting rights and share capital |
21 September 2012 | Directorate Change |
18 September 2012 | Total voting rights and share capital |
28 August 2012 | Additional Listing of shares |
9 August 2012 | Notification of major interest in BTG plc shares |
8 August 2012 | Notification of major interest in BTG plc shares |
8 August 2012 | Research Update |
1 August 2012 | Notification of major interest in BTG plc shares |
31 July 2012 | Total voting rights and share capital |
26 July 2012 | Directors' Interests in shares of BTG plc |
25 July 2012 | Total voting rights and share capital |
18 July 2012 | Total voting rights and share capital |
17 July 2012 | Results of 2011 AGM |
17 July 2012 | AGM and Interim Management Statement |
16 July 2012 | Annual Information Update 2012 |
Copies of the above announcements can be downloaded from the Company's website (www.btgplc.com) or obtained from the Company Secretary at the Company's Registered Office, 5 Fleet Place, London, EC4M 7RD
(2) Documents filed at Companies House
All of the documents listed below were filed with Companies House in Cardiff on or around the dates indicated.
Date of filing | Brief Description of document |
24 June 2013 | Auditor's Resignation |
31 May 2013 | Form SH01 Statement of Capital |
7 May 2013 | Form SH01 Statement of Capital |
28 March 2013 | Form SH01 Statement of Capital |
28 February 2013 | Form SH01 Statement of Capital |
7 February 2013 | Form SH01 Statement of Capital |
2 January 2013 | Form AP01 Appointment of Richard Wohanka as Director |
2 January 2013 | Form SH01 Statement of Capital |
17 December 2012 | Form AR01 Annual Return |
3 December 2012 | Form SH01 Statement of Capital |
19 November 2012 | Form SH01 Statement of Capital |
1 October 2013 | Form SH01 Statement of Capital |
26 September 2013 | Form TM01 Resignation of Peter Chambre as Director |
1 August 2013 | Forms SH01 Statement of Capital |
25 July 2013 | Group Accounts made up to 31 March 2011 |
23 July 2013 | Filing of special resolutions passed at AGM |
Copies of documents filed at Companies House can be obtained from Companies House or obtained from the Company Secretary at the Company's Registered Office. 5 Fleet Place, London EC4M 7RD
CONTACT: Andy Burrows
Director of Investor Relations
Telephone: 020 7575 1741